DYNE THERAPEUTICS INC's ticker is DYN and the CUSIP is 26818M108. A total of 117 filers reported holding DYNE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.10 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,583,386 | -25.0% | 846,360 | -5.9% | 0.00% | 0.0% |
| Q2 2023 | $10,117,035 | +7.3% | 899,292 | +9.9% | 0.00% | – |
| Q1 2023 | $9,424,650 | +41.6% | 818,112 | +42.5% | 0.00% | -100.0% |
| Q4 2022 | $6,654,051 | +615.5% | 574,120 | +683.9% | 0.00% | – |
| Q3 2022 | $930,000 | +86.0% | 73,242 | +0.6% | 0.00% | – |
| Q2 2022 | $500,000 | -28.7% | 72,833 | +0.1% | 0.00% | – |
| Q1 2022 | $701,000 | +242.0% | 72,767 | +323.1% | 0.00% | – |
| Q4 2021 | $205,000 | -93.8% | 17,200 | -91.9% | 0.00% | – |
| Q1 2021 | $3,284,000 | +33.0% | 211,483 | +79.8% | 0.00% | – |
| Q4 2020 | $2,470,000 | +4.0% | 117,600 | 0.0% | 0.00% | – |
| Q3 2020 | $2,374,000 | – | 117,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vida Ventures Advisors, LLC | 2,960,046 | $20,335,000 | 17.18% |
| MPM ASSET MANAGEMENT LLC | 4,951,303 | $34,015,000 | 14.35% |
| Atlas Venture Life Science Advisors, LLC | 8,934,902 | $61,383,000 | 10.26% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 3,865 | $562,568,000 | 5.87% |
| Logos Global Management LP | 2,900,000 | $19,923,000 | 3.66% |
| Deep Track Capital, LP | 3,500,000 | $24,045,000 | 1.58% |
| HighVista Strategies LLC | 241,867 | $1,662,000 | 1.00% |
| Monashee Investment Management LLC | 319,536 | $2,195,000 | 0.80% |
| RA Capital Management | 2,805,045 | $19,271,000 | 0.51% |
| Vivo Capital, LLC | 577,642 | $3,968,000 | 0.40% |